Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML) - Keßler, Torsten; Müller-Tidow, Carsten (Annals of hematology, 2019)
Gesehen am 14.06.2019